ARS Pharmaceuticals Cash Flow Statement 2019-2024 | SPRY

Fifteen years of historical annual cash flow statements for ARS Pharmaceuticals (SPRY).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-54.37$-34.68$-20.24$-32.95$-23.97
$-6.81$0.32$0.21$0.67$0.62
$9.24$7.04$2.83$3.71$1.15
$2.43$7.36$3.04$4.38$1.77
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$-4.55$-2.47$-1.33$-4.42$-0.71
$-7.33$-12.75$-0.36$-2.63$3.30
$-59.27$-40.08$-17.56$-31.20$-18.90
$-0.18$-0.20$-0.06$-0.92$-0.10
$0$0$0$0$0
$0$0$0$0$0
$-87.01$0$0$0$0
$0$0$0$0$0
$-87.01$0$0$0$0
$0$0$0$0$0
$-87.18$-0.20$-0.06$-0.92$-0.10
$0$0$0$0$0
$0$-8.68$-1.82$-0.70$-1.40
$0$-8.68$-1.82$-0.70$-1.40
$6.90$0.57$0.17$258$0.02
$6.90$0.57$54.98$412$10.02
$0$0$0$0$0
$0$199$0$-2.61$-0.01
$6.90$191$53.16$409$8.61
$-139.55$150$35.54$376$-10.38
$9.24$5.84$2.83$2.64$0.15
$0$0$0$0$0